Vald, a Brisbane, Australia-based health technology company for musculoskeletal (“MSK”) health professionals, received a growth equity investment from FTV Capital.
The amount of the deal was not disclosed. As part of this growth investment, Alex Mason and Justin Levine, vice president at FTV Capital, joined VALD’s board of directors.
The company intends to use the funds to grow its global team into new markets, launch new product offerings and capabilities, and continue to utilize AI to create applications for its proprietary dataset of MSK health records.
Led by CEO Laurie Malone, VALD is delivering a comprehensive suite of MSK technologies that enable health, performance and tactical clinicians, ranging from small physical therapy and athletic training practices to large health systems, professional sports teams, leagues and tactical operators, to enhance diagnostic capabilities and capture real-time data, thus driving better outcomes.
Since its founding in 2015, VALD has demonstrated growth with revenue more than tripling since 2021, staff in over 30 countries and a dataset of MSK records roughly doubling each year. The company serves global blue-chip customers including over 75 percent of all major league sports franchises (e.g., NFL, NBA, MLB, NHL and MLS), over 90 percent of Power 5 NCAA colleges, 20 Premier League teams, the U.S. Olympic Team, branches of the U.S. military and thousands of leading health systems and clinics.
FinSMEs
25/09/2024